-
Aptinyx Bags $70M Financing to Fuel Expanding Pipeline
biospace
December 20, 2017
Aptinyx closed on a Series B financing worth $70 million.
-
AbbVie, Pfizer Jump in on Newly-Launched Jnana Therapeutics' $50M Funding Round
biospace
December 18, 2017
Jnana Therapeutics launched with a $50 million Series A financing yesterday. Seed funders Polaris Partners and Avalon Ventures were joined in the round by Versant Ventures, AbbVie Ventures and Pfizer R&D Innovate.
-
Singapore medTech company Advent Access raises S$2.6 Million in Pre-Series A financing
biospectrumasia
December 14, 2017
Singapore medTech company Advent Access raises S$2.6 Million in Pre-Series A financing The investment was made through the Med Tech Alliance
-
Advent Access raises S$2.6 million pre-series A financing
biospectrumasia
December 13, 2017
New funds will be used to submit CE-mark filing of av-Guardian in preparation for global commercialisation and to complete ongoing international clinical trial.
-
Metacrine announces completion of series b financing
biospectrumasia
December 08, 2017
Over the course of the past year, Metacrine has advanced its lead asset, MET409, an oral non-bile acid FXR agonist, into late stage IND-enabling studies
-
GenomiCare Biotechnology Announces the Completion of Series A Financing--Dedicated to Precise Medici
biospectrumasia
December 04, 2017
Founded in 2015, GenomiCare is headquartered in Zhangjiang Hi-tech Park, Shanghai. It respectively owns an independent lab in Shanghai Zhangjiang Yaogu and a medical lab in Qidong, Jiangsu.
-
Codiak BioSciences closes $76.5 million Series C financing
biospectrumasia
December 01, 2017
Proceeds will carry first drug candidates into clinical trials
-
Step Pharma completes €14.5 million Series A financing
biospectrumasia
November 24, 2017
CTPS1 is a novel target discovered at the Imagine Institute (Paris, France) in rare genetic disease patients exhibiting deficiency in this enzyme involved in CTP nucleotide production
-
Just China secures closing of Series B financing
biospectrumasia
August 11, 2017
Globally, Just China has already established clinical development and CMC capabilities with a strong pipeline consisting of both bionovel and biosimilar products.
-
MDV assigns $57 million to support new high growth sector
biospectrumasia
August 10, 2017
MDV assigns $57 million to support new high growth sector Over the past 12 years, MDV has disbursed over RM8.8 billion (US$2.52 billion) in financing to more than 700 technology projects undertaken by SMEs.